Literature DB >> 3632298

Histologic typing of ovarian tumors.

R E Scully, L H Sobin.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3632298

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN： 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  9 in total

1.  ADP-ribosylation factor-like 4C (ARL4C), a novel ovarian cancer metastasis suppressor, identified by integrated genomics.

Authors:  Dan Su; Dionyssios Katsaros; Shenhua Xu; Haiyan Xu; Yun Gao; Nicoletta Biglia; Jianguo Feng; Lisha Ying; Ping Zhang; Chiara Benedetto; Herbert Yu
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

2.  Long non-coding RNAs, ASAP1-IT1, FAM215A, and LINC00472, in epithelial ovarian cancer.

Authors:  Yuanyuan Fu; Nicoletta Biglia; Zhanwei Wang; Yi Shen; Harvey A Risch; Lingeng Lu; Emilie Marion Canuto; Wei Jia; Dionyssios Katsaros; Herbert Yu
Journal:  Gynecol Oncol       Date:  2016-09-23       Impact factor: 5.482

3.  PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer.

Authors:  Dan Su; Haiyan Xu; Jianguo Feng; Yun Gao; Linhui Gu; Lisha Ying; Dionyssios Katsaros; Herbert Yu; Shenhua Xu; Ming Qi
Journal:  J Transl Med       Date:  2012-02-27       Impact factor: 5.531

4.  The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer.

Authors:  Shouzhen Chen; Xujing Dai; Yifei Gao; Fang Shen; Jingxin Ding; Qi Chen
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

5.  Hormone receptors expression in ovarian cancer taking into account menopausal status: a retrospective study in Chinese population.

Authors:  Fang Shen; Xuyin Zhang; Yiqun Zhang; Jingxin Ding; Qi Chen
Journal:  Oncotarget       Date:  2017-08-14

6.  Vitamin D receptor upregulates lncRNA TOPORS-AS1 which inhibits the Wnt/β-catenin pathway and associates with favorable prognosis of ovarian cancer.

Authors:  Yuanyuan Fu; Dionyssios Katsaros; Nicoletta Biglia; Zhanwei Wang; Ian Pagano; Marcus Tius; Maarit Tiirikainen; Charles Rosser; Haining Yang; Herbert Yu
Journal:  Sci Rep       Date:  2021-04-05       Impact factor: 4.379

7.  Genotyping of stathmin and its association with clinical factors and survival in patients with ovarian cancer.

Authors:  Lisha Ying; Dan Su; Jianqing Zhu; Shenglin Ma; Dionyssios Katsaros; Herbert Yu
Journal:  Oncol Lett       Date:  2013-01-18       Impact factor: 2.967

8.  Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications.

Authors:  H Gakiopoulou; P Korkolopoulou; G Levidou; I Thymara; A Saetta; C Piperi; N Givalos; I Vassilopoulos; K Ventouri; A Tsenga; A Bamias; M-A Dimopoulos; E Agapitos; E Patsouris
Journal:  Br J Cancer       Date:  2007-10-16       Impact factor: 7.640

9.  The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women.

Authors:  Fang Shen; Shouzhen Chen; Yifei Gao; Xujing Dai; Qi Chen
Journal:  Oncotarget       Date:  2017-08-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.